Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials

被引：0
|
作者：
Laukhtina, E. [1 ]
Mori, K. [2 ]
Mostafaei, H. [2 ]
Merseburger, A. S. [3 ]
Nyirady, P. [4 ]
Moschini, M. [5 ]
Quhal, F. [2 ]
Pradere, B. [2 ]
Sari, Motlagh R. [2 ]
Schuettfort, V. M. [2 ]
Enikeev, D. [1 ]
Shariat, S. F. [2 ]
机构：
[1] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[2] Med Univ Vienna, Dept Urol, Vienna, Austria
[3] Univ Hosp Schleswig Holstein, Dept Urol, Lubeck, Germany
[4] Semmelweis Univ, Dept Urol, Budapest, Hungary
[5] Luzerner Kantonsspital, Dept Urol, Luzern, Switzerland
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0834
引用
收藏
页码：S1164 / S1165
页数：2
相关论文
共 50 条
  • [41] Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Sterling, Lee H.
    Windle, Sarah B.
    Filion, Kristian B.
    Touma, Lahoud
    Eisenberg, Mark J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [42] Efficacy of Bevacizumab in the First-Line Treatment of Patients with RAS Mutations Metastatic Colorectal Cancer: a Systematic Review and Network Meta-Analysis
    Zhou, Mingyi
    Yu, Ping
    Qu, Jinglei
    Chen, Ying
    Zhou, Yang
    Fu, Lingyu
    Zhang, Jingdong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 40 (1-2) : 361 - 369
  • [43] Combination therapy with checkpoint inhibitors for first-line treatment of advanced renal cell carcinoma: A systematic review and meta-analysis of randomized controlled trials
    Thein, K. Z.
    Mogollon-Duffo, F.
    Swarup, S.
    Sultan, A.
    Yendala, R.
    Jahan, N.
    Quirch, M.
    Ball, S.
    Htut, T. Win
    D'Cunha, N.
    Rehman, S.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] A systematic review and network meta-analysis of first-line treatment options in patients metastatic renal cell carcinoma
    Bin Riaz, Irbaz
    Ryu, Alexander J.
    Yao, Yuan
    Siddiqi, Rabbia
    Mathew, Jessey
    Sipra, Qurat Ul Ain Riaz
    Zahoor, Haris
    Wang, Zhen
    Murad, M. Hassan
    Pagliaro, Lance C.
    Costello, Brian Addis
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
    Abdelazeem, Basel
    Abbas, Kirellos Said
    Labieb, Fatma
    Arida, Abdul Karim
    El-Shahat, Nahla Ahmed
    Shehata, Joseph
    Kandah, Emad
    Malik, Bilal
    Akanbi, Maxwell
    Rafae, Abdul
    Wahab, Ahsan
    Ehsan, Hamid
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) : 1127 - 1140
  • [46] The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis
    Li, Yan
    Zhou, Yaoyao
    Hong, Yonglan
    He, Meizhi
    Wei, Shuyi
    Yang, Chen
    Zheng, Dayong
    Liu, Feiye
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [47] FIRST-LINE HELICOBACTER PYLORI ERADICATION REGIMENS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Zhao, X.
    Wu, W.
    VALUE IN HEALTH, 2016, 19 (03) : A317 - A317
  • [48] Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis
    Monteiro, Fernando Sabino Marques
    Soares, Andrey
    Mollica, Veronica
    Leite, Caio Abner
    Carneiro, Andre Paterno Castello Dias
    Rizzo, Alessandro
    Bourlon, Maria T.
    Sasse, Andre Deeke
    Santoni, Matteo
    Gupta, Shilpa
    Massari, Francesco
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 196
  • [49] First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis
    Cheng, Ji
    Cai, Ming
    Shuai, Xiaoming
    Gao, Jinbo
    Wang, Guobin
    Tao, Kaixiong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [50] Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLC
    Luciani, Andrea
    Dottorini, Lorenzo
    Battaiotto, Elena
    Petrelli, Fausto
    ANTI-CANCER DRUGS, 2024, 35 (06) : 576 - 583
12345